SPPI.US
id: 1592
Spectrum Pharmaceuticals (SPPI) $15.95M Investor Settlement
The court has approved the settlement.
$15,950,000
Cash SettlementD. Nevada
Court2:21-cv-01612
Case number03/07/2018
Class period Start08/05/2021
Class period EndSpectrum Pharmaceuticals ($SPPI) has agreed to settle $15.95 million with investors to resolve claims that it misled them about the effectiveness and FDA approval prospects of its two lead drug candidates.
Case Type
US Securities Class Action
Case Status
Preliminary Approved Settlement
Alleged Offence
Misleading Statements,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.06
Filing date
08/31/2021
Plaintiffs
International Trading Group
Attorneys
Robbins Geller Rudman & Dowd LLP
Defendants
Joseph W. Turgeon ; Kurt A. Gustafson; Francois J. Lebel, M.D. ; Thomas J. Riga
Judge
Cristina D. Silva
Administrator
Verita Global
Attorney fee
$4,985,000
Trades matching type
FIFO
Frequently Asked Questions
Who is eligible for this settlement?
Do I have to sell securities to be eligible?
How long does the payout process take?
How much will my payment be?
How to get your payout?
What is 11th.com?